Geneoscopy is just smarter...

Quote

anonymous

Guest
Looks like distribution of their test is figured out, AND the ease of ordering, AND the resulting into their EMR to get credit for quality measures.

This will absolutely count towards quality measures, as it will be seen by the FDA, USPSTF, (NCQA & HEDIS) as an equivalent test. If you don't agree, ask yourself how many FIT or FOBT-G tests are on the market that count towards quality measures?

Just a smarter option, with a company that is easier to work with. No need for reps knocking on the door and dragging along the managers, SAM's, Health Equity, etc. No more parades of Exact people needing to feel important and talking about 10 year old technology.

Bye Bye Cologuard. This will destroy Exact's profitability in 2024.
 






anonymous said:
Looks like distribution of their test is figured out, AND the ease of ordering, AND the resulting into their EMR to get credit for quality measures.

This will absolutely count towards quality measures, as it will be seen by the FDA, USPSTF, (NCQA & HEDIS) as an equivalent test. If you don't agree, ask yourself how many FIT or FOBT-G tests are on the market that count towards quality measures?

Just a smarter option, with a company that is easier to work with. No need for reps knocking on the door and dragging along the managers, SAM's, Health Equity, etc. No more parades of Exact people needing to feel important and talking about 10 year old technology.

Bye Bye Cologuard. This will destroy Exact's profitability in 2024.
Click to expand...

Forgot the link:

Geneoscopy Signs Multi-Year Agreement with Labcorp to Distribute Noninvasive Multi-Target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test - Geneoscopy - Transforming Gastrointestinal Health
 


















anonymous said:
Looks like distribution of their test is figured out, AND the ease of ordering, AND the resulting into their EMR to get credit for quality measures.

This will absolutely count towards quality measures, as it will be seen by the FDA, USPSTF, (NCQA & HEDIS) as an equivalent test. If you don't agree, ask yourself how many FIT or FOBT-G tests are on the market that count towards quality measures?

Just a smarter option, with a company that is easier to work with. No need for reps knocking on the door and dragging along the managers, SAM's, Health Equity, etc. No more parades of Exact people needing to feel important and talking about 10 year old technology.

Bye Bye Cologuard. This will destroy Exact's profitability in 2024.
Click to expand...


Tell me you know nothing about USPSTF and insurance coverage without saying you know nothing about USPSTF and insurance coverage hahahahah
 






True the poster is optimistic about timing, BUT it’s a given that they will receive both USPFTF and coverage, just a matter of time. And Exact will again miss earnings for Q2 because it’s cocky attitudes like this that are sinking this place. Keep laughing it’s coming for you
 












Top Bottom
Back
Quote